CSPC Pharma (01093) spent HK $29.8096 million to repurchase 6.44 million shares on September 17th.
Shiyao Group (01093) announced that the company spent HK$2980.96 million on September 17, 2024...
CSPC PHARMA (01093) announced that the company repurchased 6.44 million shares for a total of 29.8096 million Hong Kong dollars on September 17, 2024, with a buyback price of 4.58-4.66 Hong Kong dollars per share.
Related Articles
From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?
New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
State-owned funds and computing power are the new forces rising: the battle for AI infrastructure in the Greater Bay Area seen from GD-HKGBA HLDGS (01396) receiving investment from Futian State-owned assets.
From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?
New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
State-owned funds and computing power are the new forces rising: the battle for AI infrastructure in the Greater Bay Area seen from GD-HKGBA HLDGS (01396) receiving investment from Futian State-owned assets.
RECOMMEND
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026
